Sereflo (fluticasone propionate salmeterol xinafoate): Reviews and patient testimonials
Back to the list of medications
Medication indications
Sereflo 25 microgram/125 microgram per actuation pressurised inhalation, suspension
Sereflo is indicated for use in adults with asthma 18 years of age and older only.
Sereflo is indicated in the regular treatment of patients with moderate to severe asthma where use of a combination product (long-acting β2 agonist and inhaled corticosteroid) is appropriate:
- patients not adequately controlled on a lower strength corticosteroid combination product
or
- patients already adequately controlled on an inhaled corticosteroid in a mid or high strength and a long-acting β2 agonist.
Sereflo 25 microgram/250 microgram per actuation pressurised inhalation, suspension
Sereflo is indicated for use in adults with asthma 18 years of age and older only.
Sereflo is indicated in the regular treatment of patients with moderate to severe asthma where use of a combination product (long-acting β2 agonist and inhaled corticosteroid) is appropriate:
- patients not adequately controlled on a lower strength corticosteroid combination product
or
- patients already adequately controlled on an inhaled corticosteroid in a mid or high strength and a long-acting β2 agonist.
Route of administration: opinion.traitement.inhalation
Molecule: fluticasone propionate, salmeterol xinafoate
Tips and advice of the community
Join Carenity and be the first to give your opinion on this medication.